Research IPOs and Discover New Stocks
Ascentage Pharma Group International, a commercial-stage Chinese biotech developing small molecule inhibitors for cancer, raised $126 million by offering 7.3 million ADSs at $17.25, below the as-converted last close of its shares on the Hong Kong Exchange...read more
Venture Global, a US export-focused LNG producer operating in Louisiana, raised $1.8 billion by offering 70 million shares at $25, the midpoint of the downwardly revised range of $23 to $27. The company originally filed to offer 50 million shares at a...read more
Aardvark Therapeutics, a Phase 3 biotech developing novel small molecule therapies for metabolic diseases, filed on Thursday with the SEC to raise up to $100 million in an initial public offering.Aardvark's wholly-owned lead candidate, ARD-101 (denatonium...read more
IPO PRO
TIP
Researching by industry will help you uncover new investment ideas based on new and emerging technologies and industries. Click on an industry to learn more about IPOs launching soon, then use IPO Pro to further research historical performance and upcoming IPOs.
TRY IPO PRO| Ticker | Company | Ticker | Shares (M) | Price Range | Deal Size ($M) | Underwriters | |
|---|---|---|---|---|---|---|---|
| VG | Venture Global | VG | 00/00/00 | 70.0 | $23.00 - $27.00 | $1,750 | Goldman JP Morgan |
| AAPG | Ascentage Pharma | AAPG | 00/00/00 | 7.3 | $17.25 - $17.25 | $126 | JP Morgan Citi |
IPO PRO TIP
Create custom screens and filters to see when IPOs are coming up. Explore full IPO Calendar
| Ticker | Company | Ticker | Offer Date | Deal Size ($M) | Current Price | Today's Change | Return from IPO |
|---|---|---|---|---|---|---|---|
| AAPG | Ascentage Pharma | AAPG | 01/23/25 | $126 | $17.25 |
n/a
n/a
|
n/a |
| VG | Venture Global | VG | 01/23/25 | $1,750 | $24.68 |
$-0.32
(-1.3%)
|
-1.3% |
| SKBL | Skyline Builders | SKBL | 01/22/25 | $6 | $4.13 |
$-0.53
(-11.4%)
|
3.3% |
IPO PRO TIP
The IPO price is the price the underwriters will sell stock to institutional and accredited investors. Learn more at IPO University
Get the Investment Case
Enhance your knowledge with IPO Pro. Screen for new stocks and find opportunities that others miss.
Start your 7-day trial of IPO Pro
